お知らせ • May 11
Bayer CropScience Limited to Report Q4, 2026 Results on May 26, 2026 Bayer CropScience Limited announced that they will report Q4, 2026 results at 12:15 PM, Indian Standard Time on May 26, 2026 Reported Earnings • Feb 12
Third quarter 2026 earnings released: EPS: ₹21.29 (vs ₹7.61 in 3Q 2025) Third quarter 2026 results: EPS: ₹21.29 (up from ₹7.61 in 3Q 2025). Revenue: ₹11.2b (up 6.2% from 3Q 2025). Net income: ₹957.0m (up 180% from 3Q 2025). Profit margin: 8.5% (up from 3.2% in 3Q 2025). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. お知らせ • Jan 27
Bayer CropScience Limited to Report Q3, 2026 Results on Feb 11, 2026 Bayer CropScience Limited announced that they will report Q3, 2026 results on Feb 11, 2026 Price Target Changed • Nov 26
Price target decreased by 7.5% to ₹5,315 Down from ₹5,748, the current price target is an average from 9 analysts. New target price is 16% above last closing price of ₹4,588. Stock is down 21% over the past year. The company is forecast to post earnings per share of ₹142 for next year compared to ₹126 last year. Reported Earnings • Nov 08
Second quarter 2026 earnings released: EPS: ₹33.98 (vs ₹30.33 in 2Q 2025) Second quarter 2026 results: EPS: ₹33.98 (up from ₹30.33 in 2Q 2025). Revenue: ₹15.7b (down 9.8% from 2Q 2025). Net income: ₹1.53b (up 12% from 2Q 2025). Profit margin: 9.7% (up from 7.8% in 2Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. お知らせ • Oct 18
Bayer CropScience Limited to Report Q2, 2026 Results on Nov 07, 2025 Bayer CropScience Limited announced that they will report Q2, 2026 results on Nov 07, 2025 Upcoming Dividend • Jul 31
Upcoming dividend of ₹35.00 per share Eligible shareholders must have bought the stock before 07 August 2025. Payment date: 20 September 2025. Payout ratio is on the higher end at 99%, and the cash payout ratio is above 100%. Trailing yield: 2.0%. Within top quartile of Indian dividend payers (1.2%). Higher than average of industry peers (0.7%). Reported Earnings • Jul 25
Full year 2025 earnings released: EPS: ₹126 (vs ₹165 in FY 2024) Full year 2025 results: EPS: ₹126 (down from ₹165 in FY 2024). Revenue: ₹54.7b (up 7.2% from FY 2024). Net income: ₹5.68b (down 23% from FY 2024). Profit margin: 10% (down from 14% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.3% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. お知らせ • Jul 21
Bayer CropScience Limited to Report Q1, 2026 Results on Aug 06, 2025 Bayer CropScience Limited announced that they will report Q1, 2026 results on Aug 06, 2025 Declared Dividend • Jul 05
Final dividend of ₹35.00 announced Dividend of ₹35.00 is the same as last year. Ex-date: 7th August 2025 Payment date: 20th September 2025 Dividend yield will be 1.9%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is not adequately covered by earnings (99% earnings payout ratio) nor is it covered by cash flows (254% cash payout ratio). The dividend has increased by an average of 37% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 9.9% to bring the payout ratio under control. EPS is expected to grow by 76% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. お知らせ • Jul 03
Bayer CropScience Limited, Annual General Meeting, Aug 21, 2025 Bayer CropScience Limited, Annual General Meeting, Aug 21, 2025, at 11:30 Indian Standard Time. お知らせ • Jun 12
Sekhar Natarajan Do Not Seek for 2nd Term as an Independent Director of Bayer CropScience Limited and to Step Down as Chairman of the Audit Committee and as Member of the Nomination and Remuneration Committee and Risk Management Committee, Effective August 6, 2025 Bayer CropScience Limited announced the completion of the 1st term of Mr. Sekhar Natarajan, as an Independent Director of the Company with effect from the close of business hours of August 6, 2025. Mr. Natarajan has communicated his decision not to seek reappointment for a 2nd term as an Independent Director of the Company and hence he will cease to be an Independent Director of the Company at the end of his current term. Consequently, he shall also step down as the Chairman of the Audit Committee and as Member of the Nomination and Remuneration Committee and Risk Management Committee of the Company effective August 6, 2025. Reported Earnings • May 28
Full year 2025 earnings released: EPS: ₹126 (vs ₹165 in FY 2024) Full year 2025 results: EPS: ₹126 (down from ₹165 in FY 2024). Revenue: ₹54.7b (up 7.3% from FY 2024). Net income: ₹5.68b (down 23% from FY 2024). Profit margin: 10% (down from 14% in FY 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 9.1% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. お知らせ • May 28
Bayer Cropscience Limited Recommends Final Dividend for the Year Ended March 31, 2025 The Board of Directors of Bayer CropScience Limited has recommended a final dividend of INR 35/- per share for the year ended March 31, 2025 amounting to INR 1,573 Million for 44,942,092 Equity Shares of INR 10/- each. お知らせ • May 05
Bayer CropScience Limited to Report Q4, 2025 Results on May 26, 2025 Bayer CropScience Limited announced that they will report Q4, 2025 results on May 26, 2025 Reported Earnings • Feb 12
Third quarter 2025 earnings released: EPS: ₹7.61 (vs ₹20.72 in 3Q 2024) Third quarter 2025 results: EPS: ₹7.61 (down from ₹20.72 in 3Q 2024). Revenue: ₹10.6b (up 11% from 3Q 2024). Net income: ₹342.0m (down 63% from 3Q 2024). Profit margin: 3.2% (down from 9.7% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year. お知らせ • Jan 21
Bayer CropScience Limited to Report Nine Months, 2025 Results on Feb 11, 2025 Bayer CropScience Limited announced that they will report nine months, 2025 results on Feb 11, 2025 お知らせ • Dec 30
Bayer CropScience Limited Announces Cessation of K.S. Harish, Country Group Head - Human Resources Bayer CropScience Limited announced that Mr. K.S. Harish, Country Group Head - Human Resources, who is currently designated as Senior Management Personnel (SMP) of the Company will transition to a new role within the organization and due to this change in role, he shall cease to be an SMP at the end of business hours on December 31, 2024. Declared Dividend • Nov 16
First half dividend of ₹90.00 announced Shareholders will receive a dividend of ₹90.00. Ex-date: 28th November 2024 Payment date: 11th December 2024 Dividend yield will be 2.1%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is covered by both earnings (27% earnings payout ratio) and cash flows (61% cash payout ratio). The dividend has increased by an average of 38% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 88% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Nov 14
Second quarter 2025 earnings released: EPS: ₹30.33 (vs ₹49.60 in 2Q 2024) Second quarter 2025 results: EPS: ₹30.33 (down from ₹49.60 in 2Q 2024). Revenue: ₹17.6b (up 8.9% from 2Q 2024). Net income: ₹1.36b (down 39% from 2Q 2024). Profit margin: 7.7% (down from 14% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 8% per year and the company’s share price has also increased by 8% per year. お知らせ • Nov 06
Bayer CropScience Limited to Report Q2, 2025 Results on Nov 13, 2024 Bayer CropScience Limited announced that they will report Q2, 2025 results on Nov 13, 2024 お知らせ • Aug 14
Bayer CropScience Limited Appoints Radhika Rajan as Non-Executive Woman Independent Director Bayer CropScience Limited at its AGM held on August 14, 2024 approved appointment of Ms. Radhika Rajan (DIN: 00499485) as the Non-Executive Woman Independent Director of the Company. お知らせ • Jul 30
Bayer CropScience Limited to Report Q1, 2025 Results on Aug 08, 2024 Bayer CropScience Limited announced that they will report Q1, 2025 results on Aug 08, 2024 Upcoming Dividend • Jul 25
Upcoming dividend of ₹35.00 per share Eligible shareholders must have bought the stock before 01 August 2024. Payment date: 13 September 2024. Payout ratio is on the higher end at 85%, however this is supported by cash flows. Trailing yield: 2.1%. Within top quartile of Indian dividend payers (1.1%). Higher than average of industry peers (0.7%). Reported Earnings • Jul 23
Full year 2024 earnings released: EPS: ₹165 (vs ₹169 in FY 2023) Full year 2024 results: EPS: ₹165 (down from ₹169 in FY 2023). Revenue: ₹51.0b (flat on FY 2023). Net income: ₹7.41b (down 2.3% from FY 2023). Profit margin: 14% (in line with FY 2023). Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Declared Dividend • Jul 05
Final dividend increased to ₹35.00 Dividend of ₹35.00 is 17% higher than last year. Ex-date: 1st August 2024 Payment date: 13th September 2024 Dividend yield will be 2.1%, which is higher than the industry average of 0.8%. Sustainability & Growth Dividend is covered by both earnings (85% earnings payout ratio) and cash flows (69% cash payout ratio). The dividend has increased by an average of 40% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 30% over the next 2 years, which should provide support to the dividend and adequate earnings cover. お知らせ • Jul 04
Bayer CropScience Limited, Annual General Meeting, Aug 14, 2024 Bayer CropScience Limited, Annual General Meeting, Aug 14, 2024, at 11:30 Indian Standard Time. Valuation Update With 7 Day Price Move • Jun 11
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to ₹6,065, the stock trades at a forward P/E ratio of 32x. Average forward P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 15% over the past three years. お知らせ • May 24
Bayer Cropscience Limited Announces Executive Changes Bayer CropScience Limited announced that at its Board of Directors meeting held on May 23, 2024, approved the following: Completion of term of five (5) years of Ms. Ketaki Bhagwati (DIN: 07367868) as a Woman Independent Director of the Company with effect from the close of business hours of July 23, 2024. She has expressed her intention to not renew her tenure, consequently, she shall also step down from Audit Committee, Corporate Social Responsibility and Environmental Social and Governance Committee and Nomination and Remuneration Committee effective same date. Resignation of Mr. Nikunjkumar Savaliya (Membership No. FCS 7048) as the Company Secretary and Compliance Officer with effect from the close of the business hours on May 31, 2024. He has decided to pursue opportunities outside of the Company. Appointment of Ms. Bharati Shetty (Membership No. A24199) as the Company Secretary and Compliance Officer of the Company with effect from July 15, 2024, as recommended by the Nomination and Remuneration Committee and approved by the Board of Directors. Ms. Bharati Shetty is a Corporate Governance Professional with over 15 years of experience in Corporate Secretarial, Merger & Acquisition, Compliance and Legal Business Partnering Role. Ms. Shetty started her cs career as a management trainee at Reliance Industries Limited in the year 2008. She has worked in the Compliance Team at L&T Infrastructure Finance handling varied roles from 2010-2015. In the year 2015, Ms . Shetty joined Bayer CropScience and was responsible for handling the entire Corporate Secretarial activities at BCSL. During her 7 years stint at Bayer, she was instrumental 1n implementation of Statutory Compliance Applications and Digital Solutionsviz. Insider Trading Compliance and E- Board Meeting at Bayer. お知らせ • May 16
Bayer CropScience Limited to Report Q4, 2024 Results on May 23, 2024 Bayer CropScience Limited announced that they will report Q4, 2024 results on May 23, 2024 Reported Earnings • Feb 05
Third quarter 2024 earnings released: EPS: ₹20.72 (vs ₹29.93 in 3Q 2023) Third quarter 2024 results: EPS: ₹20.72 (down from ₹29.93 in 3Q 2023). Revenue: ₹9.55b (down 8.0% from 3Q 2023). Net income: ₹931.0m (down 31% from 3Q 2023). Profit margin: 9.7% (down from 13% in 3Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth. お知らせ • Jan 25
Bayer CropScience Limited to Report Q3, 2024 Results on Feb 01, 2024 Bayer CropScience Limited announced that they will report Q3, 2024 results on Feb 01, 2024 New Risk • Nov 10
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 24% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (24% accrual ratio). Minor Risk Dividend is not well covered by cash flows (145% cash payout ratio). Upcoming Dividend • Nov 09
Upcoming dividend of ₹105 per share at 2.4% yield Eligible shareholders must have bought the stock before 16 November 2023. Payment date: 30 November 2023. Payout ratio is a comfortable 72% but the company is paying out more than the cash it is generating. Trailing yield: 2.4%. Within top quartile of Indian dividend payers (1.3%). Higher than average of industry peers (0.8%). Price Target Changed • Nov 06
Price target increased by 7.2% to ₹5,391 Up from ₹5,030, the current price target is an average from 7 analysts. New target price is approximately in line with last closing price of ₹5,243. Stock is up 12% over the past year. The company is forecast to post earnings per share of ₹175 for next year compared to ₹169 last year. Reported Earnings • Nov 05
Second quarter 2024 earnings released: EPS: ₹49.60 (vs ₹36.18 in 2Q 2023) Second quarter 2024 results: EPS: ₹49.60 (up from ₹36.18 in 2Q 2023). Revenue: ₹16.2b (up 11% from 2Q 2023). Net income: ₹2.23b (up 37% from 2Q 2023). Profit margin: 14% (up from 11% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 9.1% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. お知らせ • Nov 04
Bayer Cropscience Limited Announces Interim Dividend Declared for Financial Year 2023-24, Payable on November 30, 2023 Bayer CropScience Limited announced that the Board of Directors of the Company at their Meeting held on November 03, 2023, declared an Interim Dividend of INR 105 per equity share of INR 10 each for the Financial Year 2023-24. Record Date is November 16, 2023. Payment Date is November 30, 2023. お知らせ • Oct 28
Bayer CropScience Limited to Report Q2, 2024 Results on Nov 03, 2023 Bayer CropScience Limited announced that they will report Q2, 2024 results on Nov 03, 2023 お知らせ • Jul 29
Bayer CropScience Limited to Report Q1, 2024 Results on Aug 07, 2023 Bayer CropScience Limited announced that they will report Q1, 2024 results on Aug 07, 2023 Upcoming Dividend • Jul 28
Upcoming dividend of ₹30.00 per share at 3.0% yield Eligible shareholders must have bought the stock before 04 August 2023. Payment date: 16 September 2023. Payout ratio is on the higher end at 77%, and the cash payout ratio is above 100%. Trailing yield: 3.0%. Within top quartile of Indian dividend payers (1.5%). Higher than average of industry peers (0.9%). Reported Earnings • Jul 13
Full year 2023 earnings released: EPS: ₹169 (vs ₹144 in FY 2022) Full year 2023 results: EPS: ₹169 (up from ₹144 in FY 2022). Revenue: ₹51.4b (up 8.6% from FY 2022). Net income: ₹7.58b (up 18% from FY 2022). Profit margin: 15% (up from 14% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 7.8% p.a. on average during the next 3 years, compared to a 10.0% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Reported Earnings • May 25
Full year 2023 earnings released: EPS: ₹169 (vs ₹144 in FY 2022) Full year 2023 results: EPS: ₹169 (up from ₹144 in FY 2022). Revenue: ₹52.0b (up 9.9% from FY 2022). Net income: ₹7.58b (up 18% from FY 2022). Profit margin: 15% (in line with FY 2022). Revenue is forecast to grow 8.0% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 9% per year, which means it is significantly lagging earnings. お知らせ • May 19
Bayer CropScience Limited to Report Q4, 2023 Results on May 24, 2023 Bayer CropScience Limited announced that they will report Q4, 2023 results on May 24, 2023 Price Target Changed • Mar 17
Price target decreased by 9.4% to ₹5,033 Down from ₹5,557, the current price target is an average from 4 analysts. New target price is 26% above last closing price of ₹3,988. Stock is down 11% over the past year. The company posted earnings per share of ₹144 last year. お知らせ • Feb 01
Bayer CropScience Limited to Report Q3, 2023 Results on Feb 07, 2023 Bayer CropScience Limited announced that they will report Q3, 2023 results at 3:30 PM, Indian Standard Time on Feb 07, 2023 Reported Earnings • Nov 10
Second quarter 2023 earnings released: EPS: ₹36.18 (vs ₹34.29 in 2Q 2022) Second quarter 2023 results: EPS: ₹36.18 (up from ₹34.29 in 2Q 2022). Revenue: ₹14.7b (up 7.4% from 2Q 2022). Net income: ₹1.63b (up 5.5% from 2Q 2022). Profit margin: 11% (in line with 2Q 2022). Revenue is forecast to grow 9.2% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Chemicals industry in India. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Jul 28
Upcoming dividend of ₹25.00 per share Eligible shareholders must have bought the stock before 04 August 2022. Payment date: 21 September 2022. Payout ratio is a comfortable 17% but the company is paying out more than the cash it is generating. Trailing yield: 0.5%. Lower than top quartile of Indian dividend payers (1.8%). Lower than average of industry peers (0.8%). Reported Earnings • Jul 20
Full year 2022 earnings released: EPS: ₹144 (vs ₹110 in FY 2021) Full year 2022 results: EPS: ₹144 (up from ₹110 in FY 2021). Revenue: ₹47.3b (up 11% from FY 2021). Net income: ₹6.45b (up 31% from FY 2021). Profit margin: 14% (up from 12% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year whereas the company’s share price has increased by 18% per year. Reported Earnings • May 26
Full year 2022 earnings released: EPS: ₹144 (vs ₹110 in FY 2021) Full year 2022 results: EPS: ₹144 (up from ₹110 in FY 2021). Revenue: ₹47.3b (up 11% from FY 2021). Net income: ₹6.45b (up 31% from FY 2021). Profit margin: 14% (up from 12% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Non-Executive Non-Independent Director Brian Naber was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 05
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹18.87 (up from ₹10.03 loss in 3Q 2021). Revenue: ₹10.00b (up 8.9% from 3Q 2021). Net income: ₹848.0m (up ₹1.30b from 3Q 2021). Profit margin: 8.5% (up from net loss in 3Q 2021). The move to profitability was primarily driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Nov 04
Upcoming dividend of ₹125 per share Eligible shareholders must have bought the stock before 11 November 2021. Payment date: 30 November 2021. Trailing yield: 2.4%. Within top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.7%). Reported Earnings • Nov 03
Second quarter 2022 earnings released: EPS ₹34.29 (vs ₹49.97 in 2Q 2021) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: ₹13.7b (down 1.2% from 2Q 2021). Net income: ₹1.54b (down 31% from 2Q 2021). Profit margin: 11% (down from 16% in 2Q 2021). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Executive Departure • Sep 03
CFO & Executive Director Rolf Hoffmann has left the company During their tenure, earnings grew by 82% annually compared to the industry average of 45%. On the 31st of August, Rolf Hoffmann left the company after 2.2 in the role. We don't have any record of a personal shareholding under Rolf's name. Rolf is the only executive to leave the company over the last 12 months. The current median tenure of the management team is 2.75 years. Reported Earnings • Aug 15
First quarter 2022 earnings released: EPS ₹56.45 (vs ₹56.01 in 1Q 2021) The company reported a mediocre first quarter result with weaker profit margins, although earnings were flat and revenues improved. First quarter 2022 results: Revenue: ₹14.3b (up 17% from 1Q 2021). Net income: ₹2.54b (flat on 1Q 2021). Profit margin: 18% (down from 21% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 14% per year. Upcoming Dividend • Jul 20
Upcoming dividend of ₹25.00 per share Eligible shareholders must have bought the stock before 27 July 2021. Payment date: 11 September 2021. Trailing yield: 2.0%. Within top quartile of Indian dividend payers (1.4%). Higher than average of industry peers (0.7%). Reported Earnings • Jul 16
Full year 2021 earnings released: EPS ₹110 (vs ₹106 in FY 2020) The company reported a solid full year result with improved earnings and revenues, although profit margins were weaker. Full year 2021 results: Revenue: ₹42.6b (up 18% from FY 2020). Net income: ₹4.93b (up 3.9% from FY 2020). Profit margin: 12% (down from 13% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 11% per year.